Strategic Targeting for Optimal Prevention of Cancer

Part of paid clinical trials in Prosper, Texas.

Sponsor
ClinLogic LLC
Study ID
NCT03897374
Status
Recruiting
Apply to this trial

Conditions

  • Early Detection of Cancer

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Genetic Testing — DIAGNOSTIC_TEST
    Buccal swab

Study Details

The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.

Key Dates

Start date
Mar 26, 2025
Status verified
Mar 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
120,000 participants (estimated)

Primary Outcome Measure

Genomic cancer screen [ Time Frame: 120 Days ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Sunbeam ClinicalProsperTexas75078
Kiran Asma

Find similar trials in Prosper, TX

By research site
Sunbeam Clinical· Prosper, TX

Related Studies